1100 related articles for article (PubMed ID: 31057536)
1. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
Zalfa C; Paust S
Front Immunol; 2021; 12():633205. PubMed ID: 34025641
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.
Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y
Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation.
Yang Y; Li C; Liu T; Dai X; Bazhin AV
Front Immunol; 2020; 11():1371. PubMed ID: 32793192
[TBL] [Abstract][Full Text] [Related]
5. A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.
Bruno A; Ferlazzo G; Albini A; Noonan DM
J Natl Cancer Inst; 2014 Aug; 106(8):dju200. PubMed ID: 25178695
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways: Targeting Tumor-Infiltrating Myeloid-Derived Suppressor Cells for Cancer Therapy.
Di Mitri D; Toso A; Alimonti A
Clin Cancer Res; 2015 Jul; 21(14):3108-12. PubMed ID: 25967145
[TBL] [Abstract][Full Text] [Related]
9. Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua.
Vacca P; Vitale C; Munari E; Cassatella MA; Mingari MC; Moretta L
Front Immunol; 2018; 9():1897. PubMed ID: 30154799
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M
J Theor Biol; 2018 Apr; 442():1-10. PubMed ID: 29337259
[TBL] [Abstract][Full Text] [Related]
11. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.
Joshi S; Sharabi A
Pharmacol Ther; 2022 Jul; 235():108114. PubMed ID: 35122833
[TBL] [Abstract][Full Text] [Related]
12. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
13. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
15. Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT.
Tumino N; Di Pace AL; Besi F; Quatrini L; Vacca P; Moretta L
Front Immunol; 2021; 12():638841. PubMed ID: 33679798
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
17. In Brief: Myeloid-derived suppressor cells in cancer.
Solito S; Pinton L; Mandruzzato S
J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.
Arkhypov I; Lasser S; Petrova V; Weber R; Groth C; Utikal J; Altevogt P; Umansky V
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878277
[TBL] [Abstract][Full Text] [Related]
19. Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy.
J Immunother Cancer; ; . PubMed ID: 36521929
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]